Molecular Templates Layoffs - Oncology startup molecular templates is cutting 44% of its workforce and restructuring a debt agreement as it tries to stay afloat or find a buyer. Molecular templates announced significant changes in its leadership, with multiple resignations from its board of directors and the resignation of dr. Molecular templates is fighting for survival. Other biotechs listing repeat cuts in 2023 alone are molecular templates, frequency therapeutics, eqrx and talaris therapeutics. Molecular templates is fighting for survival. It’s been an eventful year so far for molecular templates—and not in a good way. ** shares of drug developer molecular templates mtem rise ~3% to $1.5 in extended trading ** company says it will reduce its workforce by ~60%, or 19 employees **. Molecular templates also announced a restructuring plan that includes reducing its current workforce as it continues to explore strategic alternatives. Eqrx has since effectively shut. Is overhauling a chunk of. It means that molecular templates paid off $27.5 million of its debt to k2, leaving an outstanding balance of around $10 million that will be paid off in the event of certain. Oncology startup molecular templates is cutting 44% of its workforce and restructuring a debt agreement as it tries to stay afloat or find a buyer. 84 employees were laid off in total from this layoff. Looking to focus on its core clinical development programs and extending its financial runway, molecular templates will be halving its headcount and letting go of a total of. (mtem) filed 1 warn layoff notice on apr 2023 in texas.
Looking To Focus On Its Core Clinical Development Programs And Extending Its Financial Runway, Molecular Templates Will Be Halving Its Headcount And Letting Go Of A Total Of.
Molecular templates is fighting for survival. ** shares of drug developer molecular templates mtem rise ~3% to $1.5 in extended trading ** company says it will reduce its workforce by ~60%, or 19 employees **. It’s been an eventful year so far for molecular templates—and not in a good way. 84 employees were laid off in total from this layoff.
Molecular Templates Announced Significant Changes In Its Leadership, With Multiple Resignations From Its Board Of Directors And The Resignation Of Dr.
Molecular templates also announced a restructuring plan that includes reducing its current workforce as it continues to explore strategic alternatives. Oncology startup molecular templates is cutting 44% of its workforce and restructuring a debt agreement as it tries to stay afloat or find a buyer. Oncology startup molecular templates is cutting 44% of its workforce and restructuring a debt agreement as it tries to stay afloat or find a buyer. (mtem) filed 1 warn layoff notice on apr 2023 in texas.
Eqrx Has Since Effectively Shut.
Other biotechs listing repeat cuts in 2023 alone are molecular templates, frequency therapeutics, eqrx and talaris therapeutics. Is overhauling a chunk of. Molecular templates is fighting for survival. It means that molecular templates paid off $27.5 million of its debt to k2, leaving an outstanding balance of around $10 million that will be paid off in the event of certain.